3177 results for «397»
3177 results
Imaging before and after TAVI - How to treat
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session on imaging before and after TAVI to learn how to better select patients for TAVI, to understand how to treat paravalvular leak and to know how to deal with and prevent valve thrombosis.
Where are we going? The symptomatic patient with moderate aortic stenosis
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentations on symptomatic patient with moderate aortic stenosis to learn to evaluate outcomes after TAVI, to better assess aortic stenosis and LV function, and to expand your knowledge in infiltrative diseases.
Diagnosis of disease type and of disease severity
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn how to better assess mitral regurgitation and how to better diagnose mitral stenosis through imaging.
Transcatheter mitral valve interventions: procedural considerations
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentations regarding transcatheter mitral valve interventions to learn how to select patients for each potential therapy and how to guide inside the cathlab.
Diagnosis and classification of tricuspid regurgitation
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the anatomy of the tricuspid valve and its challenges, to know when and how to treat tricuspid regurgitation, and to discover all about the latest classification regarding this condition.
Transcatheter tricuspid valve interventions: procedural considerations
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session on transcatheter tricuspid valve interventions to know more about what to do before planning tricuspid regurgitation interventions, to understand when to perform a right heart catheterisation and to learn how to solve complications during interventions.
Transcatheter tricuspid valve interventions: outcomes
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentations to learn how to better assess transcatheter tricuspid valve interventions results, to understand what are the endpoints after interventions as well as to learn what we can expect in future guidelines.
Multiple VHD: a diagnostic and clinical challenge
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult these presentations on multiple VHD to learn how to deal with combined valvular lesions, how to assess their severity and how to treat them.
Mixed VHD: how to manage?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn more about aortic stenosis and aortic regurgitation: how to diagnose these conditions, how to select patients for surgical or transcatheter interventions, and how to treat them.
Endocarditis: what can we suggest for the upcoming ESC guidelines?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the various challenges in treating patients with endocarditis, to understand how to better diagnose valve endocarditis and to discover new transcatheter interventions after endocarditis.
The challenge of aortic regurgitation: better imaging for better clinical practice
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn about the challenges of diagnosing aortic regurgitation and how to overcome them, to better understand the right timing for intervention based on available evidence, and to discover what tools exist to more accurately assess the severity of aortic regurgitation.
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.

Author
IMPELLA supported PCI via a single access sheath - Introduction and rapid adoption: the Power of Social Media
22 Dec 2020
This manuscript examines Impella single access technique, which provides a case example of the central role social media can play in the introduction of a new interventional approach.
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Author

Author
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.

Author